67E-15783-11257
3 vaccinations
0 coded responses
2 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 951 / CA
- Registered
- 2022-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2022-01-20
Dose 3 — Pfizer-BioNTechCo-administered: Tetanus
-
2022-01-27
Registered in v-safe
-
2022-01-27
Health check-in — day 7, dose 3Feeling: Poor · Site: Swelling · Fever · None · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | No |
| 2 | 2021-02-20 | Pfizer-BioNTech | No |
| 3 | 2022-01-20 | Pfizer-BioNTech | Tetanus |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.